Particle.news

Download on the App Store

Prostate Cancer Research Urges £18-Per-Patient Targeted NHS Screening for High-Risk Men

The UK screening committee is reassessing the policy, with a fresh recommendation expected next month.

Overview

  • The charity’s plan would invite Black men and those with a family history aged 45–69 for PSA blood tests, MRI scans and, where needed, biopsy.
  • Its analysis estimates about £25 million a year in costs, with delivery needing roughly five additional MRI scanners and 75 extra staff across the NHS.
  • Report authors say newer tools such as reflex blood tests, AI‑assisted MRI, polygenic risk scores and digital pathology can cut false positives and overtreatment.
  • Audit data show 58,218 prostate cancer diagnoses in England in 2024, a 9% increase on 2023, alongside rising use of radical treatments.
  • Supporters including Rishi Sunak back the targeted approach, though recent reports suggest the screening committee may again view routine screening as not cost‑effective.